Volume 18, Number 11—November 2012
Research
Risk for Travel-associated Legionnaires’ Disease, Europe, 2009
Julien Beauté
, Phillip Zucs, Birgitta de Jong, and for the European Legionnaires’ Disease Surveillance Network
, Phillip Zucs, Birgitta de Jong, and for the European Legionnaires’ Disease Surveillance Network
Table 3
Expected risk for Legionnaires’ disease in European travelers to nondomestic destinations in Europe, based on reference data reported by the United Kingdom, the Netherlands, France, and Denmark, Europe, 2009*†
| Destination | Risk for travelers to destination (cases/million nights) | Incidence ratio (95% CI) | Total no. cases |
|
|---|---|---|---|---|
| Reported | Estimated | |||
| Greece | 1.68 | 7.2 (4.2–12.2) | 34 | 98 |
| Italy | 1.40 | 6.0 (3.9–9.2) | 209 | 463 |
| Germany | 1.19 | 5.1 (2.9–8.7) | 22 | 353 |
| Portugal | 1.06 | 4.6 (2.1–9.0) | 20 | 44 |
| Austria | 1.01 | 4.4 (2.2–8.2) | 20 | 95 |
| Spain | 0.57 | 2.5 (1.6–3.8) | 98 | 188 |
| France | 0.53 | 2.3 (1.6–3.3) | 137 | 145 |
| Netherlands | 0.33 | 1.4 (0.8–2.4) | 21 | 26 |
| United Kingdom | 0.23 | 1.0 (Ref.) | 45 | 53 |
| Other countries | 0.90 | 3.9 (2.3–6.4) | 42 | 282 |
| Total | 0.55 | NA | 607 | 1,127 |
*A case-patient could have a travel history involving >1 country. Ref., referent; NA, not applicable.
†In the United Kingdom, reporting of Legionnaires’ disease became mandatory in 2010.
Page created: October 16, 2012
Page updated: October 16, 2012
Page reviewed: October 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.